NIH-funded research Sbir 2 grant

Low-cost, at-your-hands test to detect oral cancer early in low-resource settings

Official title: Development of an effective, low-cost, point-of-care early detection test for oral cancer in low resource settings

Funded at Vigilant Laboratories LLC · NIH-11401361 · Data updated 2026-11-12

A small, inexpensive test using a cheek or mouth rinse could help people in low-resource areas find oral cancer early.

More Oral Cancer research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionVigilant Laboratories LLC
NIH-funded
Lab location1 site (Pinecrest, United States)
Project startSeptember 1, 2025
Project endAugust 31, 2027
Funding year2026
Award (this year)$1,019,384
NIH project number5R44CA298389-02
Project IDNIH-11401361 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals at risk for oral cancer or presenting with symptoms or risk factors in low-resource settings.

Less likely to help

People without oral cancer risk factors or with conditions that do not affect the oral cavity may not benefit from this test.

What this research studies

This project aims to turn a three-biomarker oral rinse into a simple point-of-care strip test that can be used outside of advanced clinics. It uses CD44, total protein, and p16 markers plus a machine-learning model to flag people who may have oral cancer. The goal is a fast, noninvasive test that could be used in community health centers or at home with minimal equipment. The team plans to optimize the test strips and validate performance in real-world, low-resource settings.

Why it matters

Potential benefit: If successful, the test could lead to earlier diagnosis and better survival for people with oral cancer in underserved communities.

How similar studies have gone: Preliminary data show promising sensitivity and specificity, supporting further development and commercialization.

Where this research is happening

  • Vigilant Laboratories LLC
    Pinecrest, United States
    Active

Researchers

  • Principal investigator: Franzmann, Elizabeth J — Vigilant Laboratories LLC
  • Study coordinator: Franzmann, Elizabeth J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.